Beam Therapeutics Inc.BEAMNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-356.19M
↓ 213% below average
Average (7y)
$-113.96M
Historical baseline
Range
High:$-3.05M
Low:$-356.19M
CAGR
+97.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-356.19M | -94.7% |
| 2023 | $-182.93M | -592.3% |
| 2022 | $-26.42M | +76.6% |
| 2021 | $-113.08M | -0.9% |
| 2020 | $-112.10M | -32.6% |
| 2019 | $-84.52M | -152.9% |
| 2018 | $-33.42M | -994.7% |
| 2017 | $-3.05M | - |